Evaluation of the Impact of Advanced Glycation End-Products on Peripheral Neuropathy Outcomes in Type 2 Diabetes

<b>Background</b>: Type 2 diabetes (T2DM) affects over 500 million people worldwide, and over 50% of this group experience the most common complication, diabetic peripheral neuropathy (DPN). The presence of advanced glycation end-products (AGEs) has been linked with the development of DPN. The prese...

Ausführliche Beschreibung

Bibliografische Detailangaben

Hauptverfasser:	Indumathi Singh, Tushar Issar, Ann M. Poynten, Kerry-Lee Milner, Arun V. Krishnan, Roshan Dhanapalaratnam
Format:	Artigo
Sprache:	Inglês
Veröffentlicht:	MDPI AG 2024-11-01
Schriftenreihe:	Biomedicines
Schlagworte:	advanced glycation end-products diabetic peripheral neuropathy skin autofluorescence and advanced glycation end-products
Online-Zugang:	https://www.mdpi.com/2227-9059/12/11/2518
Tags:	Tag hinzufügen Keine Tags, Fügen Sie das erste Tag hinzu!